510 related articles for article (PubMed ID: 16955009)
21. Sporadic hypercalcitoninemia: clinical and therapeutic consequences.
Scheuba C; Kaserer K; Moritz A; Drosten R; Vierhapper H; Bieglmayer C; Haas OA; Niederle B
Endocr Relat Cancer; 2009 Mar; 16(1):243-53. PubMed ID: 18987170
[TBL] [Abstract][Full Text] [Related]
22. Emergence of medullary thyroid carcinoma in a family with the Cys630Arg RET germline mutation.
Machens A; Schneyer U; Holzhausen HJ; Raue F; Dralle H
Surgery; 2004 Nov; 136(5):1083-7. PubMed ID: 15523405
[TBL] [Abstract][Full Text] [Related]
23. [Surgical management of hereditary medullary carcinoma of the thyroid in patients with "RET" proto-oncogene mutation].
Calbo L; Spinelli C; Lazzara S; Melita P; Miccoli P
Chir Ital; 1998; 50(5-6):47-51. PubMed ID: 10392193
[TBL] [Abstract][Full Text] [Related]
24. Role of prophylactic thyroidectomy in RET 790 familial medullary thyroid carcinoma.
Bihan H; Baudin E; Meas T; Leboulleux S; Al Ghuzlan A; Hannoteaux V; Travagli JP; Valleur P; Guillausseau PJ; Cohen R;
Head Neck; 2012 Apr; 34(4):493-8. PubMed ID: 21688339
[TBL] [Abstract][Full Text] [Related]
25. Prophylactic thyroidectomy in the treatment of thyroid medullary carcinoma. Age for surgery?
Hassett S; Costigan C; McDermott M; Fitzgerald RJ
Eur J Pediatr Surg; 2000 Oct; 10(5):334-6. PubMed ID: 11194546
[TBL] [Abstract][Full Text] [Related]
26. [Medullary thyroid carcinoma and some of its particularities].
Sidibé el H
Sante; 2007; 17(1):51-5. PubMed ID: 17897902
[TBL] [Abstract][Full Text] [Related]
27. RET mutation status in medullary thyroid cancer(MTC) patients and the significance of genetic screening for mutations in their immediate relatives--a preliminary report.
Menon MM; Simha MR
Indian J Pathol Microbiol; 2005 Apr; 48(2):161-5. PubMed ID: 16758654
[TBL] [Abstract][Full Text] [Related]
28. [Treatment of familial medullary thyroid carcinoma].
Palestini N; Tagliabue M; Cestino L; Farnetti A; Rossetto R; Vendrame A
Minerva Chir; 2003 Dec; 58(6):801-9. PubMed ID: 14663408
[TBL] [Abstract][Full Text] [Related]
29. Medullary thyroid carcinoma: surgical treatment advances.
Dionigi G; Tanda ML; Piantanida E
Curr Opin Otolaryngol Head Neck Surg; 2008 Apr; 16(2):158-62. PubMed ID: 18327036
[TBL] [Abstract][Full Text] [Related]
30. Application of genetic screening in families with hereditary medullary thyroid carcinoma.
Frank-Raue K; Höppner W; Buhr H; Herfarth C; Ziegler R; Raue F
Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():108-10. PubMed ID: 8981015
[TBL] [Abstract][Full Text] [Related]
31. Individualization of lymph node dissection in RET (rearranged during transfection) carriers at risk for medullary thyroid cancer: value of pretherapeutic calcitonin levels.
Machens A; Lorenz K; Dralle H
Ann Surg; 2009 Aug; 250(2):305-10. PubMed ID: 19638924
[TBL] [Abstract][Full Text] [Related]
32. Invited commentary: medullary thyroid cancer: the importance of RET testing.
Evans DB; Shapiro SE; Cote GJ
Surgery; 2007 Jan; 141(1):96-9. PubMed ID: 17188173
[No Abstract] [Full Text] [Related]
33. RET proto-oncogene testing in infants presenting with Hirschsprung disease identifies 2 new multiple endocrine neoplasia 2A kindreds.
Fialkowski EA; DeBenedetti MK; Moley JF; Bachrach B
J Pediatr Surg; 2008 Jan; 43(1):188-90. PubMed ID: 18206480
[TBL] [Abstract][Full Text] [Related]
34. [The concept of "microsurgical" technique in medullary thyroid carcinoma].
Mann B; Buhr HJ; Faulhaber J
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():720-3. PubMed ID: 9931710
[TBL] [Abstract][Full Text] [Related]
35. Familial nonmultiple endocrine neoplasia medullary thyroid carcinoma: an evolving clinical entity.
McHenry CR; Oppenheim DS; Murphy T; Broughan T; Vogt D; Goldfarb WB
Surgery; 1992 Oct; 112(4):728-32; discussion 732-3. PubMed ID: 1411944
[TBL] [Abstract][Full Text] [Related]
36. Prophylactic thyroidectomy in ethnic Chinese patients with multiple endocrine neoplasia type 2A syndrome after the introduction of genetic testing.
Lau GS; Lang BH; Lo CY; Tso A; Garcia-Barcelo MM; Tam PK; Lam KS
Hong Kong Med J; 2009 Oct; 15(5):326-31. PubMed ID: 19801688
[TBL] [Abstract][Full Text] [Related]
37. Very early prophylactic thyroid surgery for infants with a mutation of the RET proto-oncogene at codon 634: evaluation of the implementation of international guidelines for MEN type 2 in a single centre.
Piolat C; Dyon JF; Sturm N; Pinson S; Bost M; Jouk PS; Plantaz D; Chabre O
Clin Endocrinol (Oxf); 2006 Jul; 65(1):118-24. PubMed ID: 16817830
[TBL] [Abstract][Full Text] [Related]
38. [Medullary thyroid carcinoma--familial or sporadic disease?].
Høie J; Jørgensen OG; Nesland JM; Møller P; Bjøro K
Tidsskr Nor Laegeforen; 1994 Oct; 114(25):2951-4. PubMed ID: 7974404
[TBL] [Abstract][Full Text] [Related]
39. Familial medullary thyroid carcinoma with noncysteine ret mutations: phenotype-genotype relationship in a large series of patients.
Niccoli-Sire P; Murat A; Rohmer V; Franc S; Chabrier G; Baldet L; Maes B; Savagner F; Giraud S; Bezieau S; Kottler ML; Morange S; Conte-Devolx B;
J Clin Endocrinol Metab; 2001 Aug; 86(8):3746-53. PubMed ID: 11502806
[TBL] [Abstract][Full Text] [Related]
40. Presymptomatic thyroidectomy in multiple endocrine neoplasia 2a.
Heizmann O; Haecker FM; Zumsteg U; Müller B; Oberholzer M; Oertli D
Eur J Surg Oncol; 2006 Feb; 32(1):98-102. PubMed ID: 16325365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]